Pfizer-BioNTech to get EU 200 million more COVID-19 shots

Pfizer and BioNTech say they have reached an agreement to supply the European Union with another 200 million doses of their COVID-19 vaccine

Virus Outbreak Japan Vaccine Explainer (Copyright 2020 The Associated Press. All rights reserved)

Pfizer and BioNTech said Wednesday they have reached an agreement to supply the European Union with another 200 million doses of their COVID-19 vaccine.

The U.S. and German companies said in a statement that the doses come on top of the 300 million initially ordered. The EU’s executive Commission has an option to request a further 100 million doses.

They said the 200 million doses are expected to be delivered this year, with an estimated 75 million of them in the second quarter.

The Pfizer-BioNTech vaccine was the first of three so far to be approved for use in the EU which faces criticism for a slow start to its vaccination campaign. The other two approved vaccines are from Moderna and AstraZeneca.